Recent AQST News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/13/2025 12:07:41 PM
- Aquestive Therapeutics Provides Business Update and Outlines Key 2025 Objectives • GlobeNewswire Inc. • 01/13/2025 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/19/2024 01:02:50 PM
- Aquestive Therapeutics Receives U.S. FDA Orphan Drug Exclusivity for Libervant® (diazepam) Buccal Film in Pediatric Patients with Seizure Clusters Ages Two to Five • GlobeNewswire Inc. • 12/19/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/02/2024 01:08:12 PM
- Aquestive Therapeutics Announces Positive FDA Feedback and Reaffirms NDA Submission Guidance for Anaphylm™ (epinephrine) Sublingual Film • GlobeNewswire Inc. • 12/02/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2024 09:24:09 PM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/14/2024 08:47:19 PM
- Aquestive Therapeutics to Participate in Two Upcoming Investor Conferences • GlobeNewswire Inc. • 11/12/2024 01:00:00 PM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 11/08/2024 10:31:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2024 09:01:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/06/2024 09:01:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/04/2024 09:40:49 PM
- Aquestive Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 11/04/2024 09:36:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/25/2024 12:05:43 PM
- Aquestive Therapeutics to Present Subsequent Analysis of Pivotal Study for Anaphylm™ (epinephrine) Sublingual Film Demonstrating Comparable PK and PD Data to Epinephrine Injection Regardless of Variable Placement or Intraoral Movement at American College • GlobeNewswire Inc. • 10/25/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2024 12:06:00 PM
- Aquestive Therapeutics Announces Positive Topline Results from Oral Allergy Syndrome (OAS) Challenge Study for Anaphylm™ (epinephrine) Sublingual Film • GlobeNewswire Inc. • 10/24/2024 12:00:00 PM
- Aquestive Therapeutics to Report Third Quarter 2024 Financial Results and Recent Business Highlights on November 4 and Host Conference Call on November 5 at 8:00 a.m. ET • GlobeNewswire Inc. • 10/21/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/16/2024 09:16:29 PM
- Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 10/02/2024 06:16:27 PM
Luke Plants Featured in U.S. Department of the Interior Report to Congress on Strategic Review of National Orphan Well Program • ZEFIF • Jan 21, 2025 10:51 AM
North Bay Resources Acquires 70% Interest in the Bishop Gold Mill, Inyo County, California • NBRI • Jan 21, 2025 9:26 AM
HealthLynked Unveils Release of ARi: A Revolutionary AI-Powered Healthcare Assistant • HLYK • Jan 21, 2025 8:00 AM
Good Gaming Inc. Announces ViaOne Services' Intent to Purchase Up to 10% of Its Common Shares in the Open Market • GMER • Jan 16, 2025 8:30 AM
Avant Technologies and Ainnova Begin Implementing and Testing Advanced AI Algorithms for Early Detection of Additional Diseases • AVAI • Jan 16, 2025 8:00 AM
VOCODIA HOLDINGS INC. (OTCMKTS: VHAI) and TRACCOM INC. (OTCMKTS: TRCC) have signed an MOU to form a Joint Venture that will Revolutionize Event Monitoring with Narrative AI • VHAI • Jan 15, 2025 2:53 PM